Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed3
Other5

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT02897167Completed
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
Mental DisordersPsychotic DisordersSchizophrenia
PrincipalinvestigatorStart date: 2016-08-01
NCT02858102Not ApplicableUnknown
Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental Disorders
Mental DisordersMetabolic Syndrome
PrincipalinvestigatorStart date: 2016-06-01
Cost-effectiveness of Interventions in First-episode Psychosis
Schizophrenia
PrincipalinvestigatorStart date: 2016-06-01
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
Schizophrenia
PrincipalinvestigatorStart date: 2015-01-01
NCT03090490Not ApplicableUnknown
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
PrincipalinvestigatorStart date: 2014-09-01
NCT02305823Phase 4Completed
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
Psychotic DisordersSchizophrenia
PrincipalinvestigatorStart date: 2005-10-01
NCT02220504Not ApplicableCompleted
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
PrincipalinvestigatorStart date: 2004-07-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University Hospital Marqués de Valdecilla, IDIVAL, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain. CIBERSAM Centro Investigación Biomédica en Red Salud Mental, Madrid, Spain

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT02897167PrincipalInvestigator

Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients

Mental DisordersPsychotic DisordersSchizophrenia
Completed
NCT02858102Not ApplicablePrincipalInvestigator

Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental Disorders

Mental DisordersMetabolic Syndrome
Unknown
NCT02916303PrincipalInvestigator

Cost-effectiveness of Interventions in First-episode Psychosis

Schizophrenia
Unknown
NCT02205437PrincipalInvestigator

Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia

Schizophrenia
Unknown
NCT02200588PrincipalInvestigator

Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP

Schizophrenia
Unknown
NCT03090490Not ApplicablePrincipalInvestigator

10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Unknown
NCT02305823Phase 4PrincipalInvestigator

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis

Psychotic DisordersSchizophrenia
Completed
NCT02220504Not ApplicablePrincipalInvestigator

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Completed

All 8 trials loaded